No significant group differences were observed on self-report scales but significant differences were found on interview-based measures with HRT-CERP being more effective than HRT-SC in reducing symptom severity.
Munur á meðferðarhópum var ekki marktækur þegar árangur var metinn með sjálfsmatskvörðum en reyndist marktækur þegar árangur var metinn í viðtölum og var HRT-CERP þá árangursríkari.